RB status governs differential sensitivity to cytotoxic and molecularly-targeted therapeutic agents

Cell Cycle
K StengelE S Knudsen

Abstract

The retinoblastoma tumor suppressor (RB) is frequently inactivated in human cancers and has been shown to modulate the anti-proliferative effects of DNA-damaging therapies. However, the impact of RB loss on response to disparately functioning cytotoxic agents as well as targeted therapies is poorly understood. Here 3T3-immortalized and Ras-transformed mouse adult fibroblasts (MAFs) containing conditional RB alleles were utilized to investigate the consequence of RB loss on cellular response to cytotoxic agents and therapies targeting the MEK and PI3K pathways. Using these models, we demonstrate that RB deficiency is associated with bypass of therapy-induced checkpoints in response to both cytotoxic and targeted treatments. Interestingly, while checkpoint bypass following treatment with cytotoxic therapy results in an agent specific increase in drug sensitivity, checkpoint bypass following treatment targeting MEK and PI3K function results in increased cellular proliferation. These results indicate that RB status differentially impacts therapeutic response and should be considered when evaluating the efficacy of molecularly targeted therapeutics.

Citations

Sep 3, 2010·Cancer Research·Hong JiangJuan Fueyo
Oct 25, 2011·PloS One·Maria Teresa Sáenz RoblesJames M Pipas
Jul 28, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Giuseppe S BoginaGiuseppe Zamboni
Aug 13, 2013·Gene·A A StepanenkoV M Kavsan
Jul 6, 2012·Bioscience Reports·Dulcie LaiXiaolong Yang
Aug 1, 2013·Oncotarget·Isabella CaligiuriFlavio Rizzolio
Feb 23, 2020·Science Translational Medicine·Florence CoussyElisabetta Marangoni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.